SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " big " 11,923 found 🔀 AI-powered Shuffle
The Big Summer Preview – Chaos Arrives in the Old World
New miniatures, rules, and more revealed for Warhammer: The Old World.
The Big Summer Preview
New jetbikes, grav vehicles and Dreadnoughts revealed for Warhammer 40,000 AND Warhammer: The Horus Heresy.
The Big Summer Preview
See the new edition of Necromunda revealed, including miniatures, rules, and more.
The Big Summer Preview – A New Animation: The Butcher’s Nails
Witness a World Eater in the grip of the Butcher’s Nails.
The Big Summer Preview – See all the reveals here
New reveals for Warhammer 40,000, Kill Team, Age of Sigmar, and more.
The Big Summer Preview – New Starter Sets and ready painted terrain
Dive into Warhammer 40,000, and fight on the battlefields of Armageddon with new terrain kits.
Caitlin Clark made the WNBA bigger. It’s still playing small
The league’s paltry one-game suspension of Alyssa Thomas after her fist to Caitlin Clark's throat barely begins to address the problem.
DC Wrap: Supreme Courts rules on immigration and gun cases
A look at the day's biggest stories in national politics
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
The Politics Hour: The big winners in MD's primary elections
Leading Democratic nominee for Montgomery County Executive Will Jawando talks about his message to voters, dark money, and data centers. Plus, Tara Jackson wins the Democratic nomination for Prince George's County State's Attorney and WAMU's Alex Koma on D.C. lawmakers greenlighting the budget.
Entrepreneurs pitched business ideas to Yahoo Finance
Yahoo Finance Executive Editor Brian Sozzi is on the hunt for the next big business breakthrough. Check out the absolute best pitches and standout moments from the innovators making waves at Cannes Lions.
Roundup: Shift in NIL / BlackBerry transitions / Agriculture aid
More inclusive: A recent NCAA rule change is shifting name, image and likeness opportunities away from only the biggest star athletes to a wider range of student-athletes. The update gives schools more structured involvement in managing and facilitating NIL deals, which reduces some of the previous free-for-all environment. As a result, athletes who are not […]
Chris Evert shares devastating health update
It is the news that no one wanted to hear about Chris Evert. Amid the Netflix press tour and her upcoming ESPN commentary duties at Wimbledon, we learned on Wednesday that she quietly stepped away to deal with a health…
Platner, Collins’ campaign spar over federal contracts
Platner released a multi-point plan he calls “a corruption crackdown,” which covers issues such as big money in politics, lobbying activities by former members of Congress, and making it more difficult for presidents to cash in on their position while in office.
Steam Summer Sale 2026 is live
The great big sale event of the hot season has landed, the Steam Summer Sale 2026 is live now with masses of games featuring big discounts.
Apple to Skip High-End M6 Mac Chips in Favor of AI-Focused M7 Line
Apple Inc. is making one of the biggest-ever changes to its Mac silicon strategy, preparing to jump ahead to a new artificial intelligence-focused chip generation for its next top-end processors.
Ranking Big 12 recruiting classes via average commit distance
The Big 12 recruiting landscape continues to change as programs continue to shuffle throughout the conference. Texas Tech is pushing to sign the nation’s No. 1 class in the 2027 cycle and it firmly sits atop the league’s recruiting rankings. The Red Raiders are the only Big 12 team with a top-25 haul, per the […]
Spent 3 days at Acadia National Park; biggest mistakes we made
We spent a few days exploring Acadia National Park in Maine. Next time we go, we'll make reservations and avoid mistakes like packing the wrong shoes.
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
Grand Theft Auto VI pre-orders open, but don’t expect a physical copy
The blockbuster launch is expected to dwarf the box office takings of the year’s biggest movies with one industry analyst predicting it could make $1bn within an hour
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
Axios House: Sports must prove it can scale as live events surge
Sports is now the single biggest driver of live viewing, and everyone is scrambling to own a piece of it
A new vision for quantum computing takes a big step forward, with new grant
A $4 million National Science Foundation grant will propel the next phase of a Yale-led project to build a quantum computer with an innovative new design.
Lane County Public Health to slash jobs as it weathers federal healthcare cuts
Lane County’s Public Health Department announced significant budget reductions as federal healthcare cuts approved by Congress in the so-called Big Beautiful Bill, or H.R.1, go into effect.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
First NYC. Now DC. Can Mamdani’s win keep powering progressives?
Candidates on the left are on a roll in the biggest, bluest cities. But doubts remain about whether they can win a national race.
MAHA is breaking up with Trump. Now what?
A coalition of wellness-conscious activists is changing course, with big implications for 2028.
World Cup: can big sports events bring us together? Recent history says yes
Although fleeting, sporting events have the enduring power to crumble divisions and highlight the beauty of kinship
Monterey Motorsports Festival Announces 2026 Entertainment Lineup Headlined by Viral DJ Duo SIDEQUEST
/PRNewswire/ -- The Monterey Motorsports Festival is turning up the volume for Monterey Car Week 2026 with its biggest entertainment lineup to date, featuring...
Elizabeth Warren says ‘frenzy’ of mergers under Trump could be reversed
Senator warns of ‘tsunami of anger’ against big companies and suggests future administrations may undo key deals
Walmart Business Targets the Invisible Work Slowing Small Business Down
Running a small business can take up a big chunk of its owner’s time. Even something as simple as ordering the breakroom snacks each month can add up, and
19 fours, 6 sixes! Vaibhav Sooryavanshi's younger brother Ashirvad Sooryavanshi hits blistering century
Young cricketer Ashirvad Sooryavanshi, just 10 years old, is making waves with his exceptional batting. He recently smashed a stunning 168 off 119 balls in a practice match, following a debut century. Despite only six months of playing, his aggressive style and big scores are drawing attention, even from his brother Vaibhav, who is currently with the Indian team.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
The Red Sox Have a Big Jarren Duran Problem
The Boston Red Sox could have a tough time selling off one of their most obvious trade chips at this year's deadline.
Family mourns man found dead in south Bexar County business as BCSO searches for shooter
Bexar County sheriff’s investigators say they have little information on a murder case that has left a big hole in the hearts of one family.
21 small products that made a huge difference in our lives and are cheaper than ever
Our favorite small, budget-friendly products have made a big difference in our lives, and they’re heavily discounted for Amazon Prime Day.
Patriots Coach Jeremy Springer Announces Engagement To NBC Sports Host Kayla Burton
NBC Sports host Kayla Burton is engaged to an NFL coach. The popular Boston-based sports media personality announced her engagement to New England Patriots special teams coordinator Jeremy Springer. The two announced their big news in a joint Instagram post Monday, sharing photos from the NFL ...
DC Wrap: Trump lashes out over Iran vote; Great American State Fair begins
A look at the day's biggest stories in national politics
DC Wrap: Trump lashes out over Iran vote; Great American State Fair begins
A look at the day's biggest stories in national politics
My Music Row Story: Big Machine Records/Nashville Harbor Records & Entertainment’s Allison Jones
With over 35 years of experience in the music industry, Allison Jones serves as EVP of A&R at [...]
USF football and all sports will feel a big impact under new NCAA eligibility rule
Players in all sports will have five years to complete five seasons. Redshirts and medical extensions are going away.
Google's Gemini 3.5 Pro release slips to July
Google's next big AI model is coming later than promised, but the company is trying to use the extra time to make it better.
Oracle's Headcount Fell by 21,000 as AI Reshapes Its Business. Here's What It Means for the Stock.
The job cuts made headlines. But the bigger story is what's funding them.
The Thunder have now officially won the Paul George trade
Time will tell but it looks like the Oklahoma City Thunder got yet another vital piece by drafting Michigan’s Aday Mara with the 13th pick in Tuesday’s NBA draft. The 7-foot-3 center proved his ability on both ends of the…
After New York’s Primary Elections, Democrats Face Five Big Questions
The anti-establishment left surged. How shaken are party leaders?
NBA rumors: The latest on Jaylen Brown's Celtics future, the Knicks' offseason plans and Anthony Edwards
The first night of the draft came and went without any big moves but there's plenty to be done
'Supergirl' review: Better than the comic, but not DC's best
Milly Alcock and Jason Momoa bring big attitude to James Gunn's relaunched DC Universe.
50 Cent Diddy documentary alleges blame for Biggie, Tupac deaths
50 Cent's new documentary chronicling the rise and fall of Sean "Diddy" Combs hit Netflix Tuesday, complete with bombshell revelations, never-before-seen footage and insider interviews.
'Voicemails for Isabelle' is Netflix's latest big hit — but viewers should expect tears
Zoey Deutch's Netflix rom-com has pleased both audiences and critics alike. But what viewers weren't expecting was how many tissues they would need while watching.
Trump cancels plan to sign major housing bill as he fights with Congress over the SAVE Act
Just hours before heading to Capitol Hill, Trump called the big, bipartisan housing bill Republicans hope to run on in the fall “of minor importance.”
Walmart buying Vibe.co stirs big buzz at Cannes Lions: analysis
Walmart scored the deal everyone's talking about at Cannes Lions this year. Buying Vibe.co signals its intent to rival Meta, Google, and Amazon.
An Olympic-sized collaboration between Lake Placid, Big Apple
Commentary: Governor Kathy Hochul’s recent announcement about New York City possibly hosting the Olympics isn’t a new idea.
Hollywood and Big Tech Are at War: Fight for Attention Underway
Meta wants to steal TV viewers, Amazon and Apple are meddling with content, and traditional media companies are pursuing megadeals to try and survive.
Behind the scenes of a successful entertainment career with Jenny Austin ’12
From interviews with big-name celebrities like Will Ferrell to assisting with casting for hit television shows like “The Summer I Turned Pretty,” Jenny Austin ’12 is living out her dreams....
The US in Brief: A big night for Zohran Mamdani
Our daily political update, featuring the stories that matter
Mamdani-backed candidates win big in New York Democratic primaries
Three congressional candidates endorsed by Mamdani win in clear sign of New York mayor’s growing influence
How wellness and longevity trends are reshaping American real estate
Health-obsessed homebuyers are splurging on cold plunges, saunas, and cryotherapy chambers. Real estate's biggest flex isn't just for the uber-rich.
Monster Fantasy Combines the Thrill of Monster Hunter with the Cosy Chill of Animal Crossing
We got hands-on with a very early build of Monster Fantasy, a hybrid adventure that gives players the flexibility to choose whether they want to seek the thrilling challenge of big game beast-hunting or the laid back chilling of just catching bugs and good vibes with their fellow villagers.
Bigger trade now an option after Sharks deal William Eklund for No. 9 draft pick
San Jose Hockey Now's Sheng Peng dissects what could be next for the Sharks after they acquired another top-10 draft pick for William Eklund.
Business owners and students alike benefit from Akron chamber’s support programs
The Greater Akron Chamber helps more than 850 small businesses in Summit and Portage counties compete with bigger businesses.
Someone got a Google Home Speaker early, and the big downside is a fixed power cable
The Google Home Speaker is set to start shipping very soon but, ahead of that, one user was able to...
Predicting the Nets 2026-27 Opening Night Starting Lineup
In the aftermath of the 2026 NBA Draft and a big trade, how do the Nets look heading into next season?
Melissa Gilbert leaves NYC amid husband Timothy Busfield's legal troubles
Melissa Gilbert is leaving the Big Apple apartment she shared with husband Timothy Busfield after eight years.
Marvin Mims gets brutally honest over Denver Broncos offseason moves
When the Denver Broncos completed their NFL blockbuster trade for Miami Dolphins wide receiver Jaylen Waddle, they moved one step closer to Super Bowl contention. A player of Waddle’s caliber almost certainly raises the ceiling of head coach Sean Payton’s…
Tickets for top entertainment events at Scotts Bluff Co. Fair go on sale Wednesday
Tickets for the ‘big three’ of the nightly entertainment at the Scotts Bluff County go on sale Wednesday morning. Starting at 9 a.m., you can get your advance tickets for the Truck and Tractor Pull…
Villanova Recruiting: Wildcats makes multiple big-time offers
The Wildcats continue to offer some big fish in multiple classes.
NBA Draft 2026 Day 1 discussion
Okay ladies and gentlemen. Today is the BIG DAY! The first round of the 2026 NBA Draft is tonight at 8 p.m. ET. Watch it on ABC (WJLA-TV) or ESPN. The Washington Wizards have the first pick of this thing barring a trade. And besides some initial reports in May about the Utah Jazz wanting […]
George Holani could be Seahawks biggest surprise player this offseason
Seahawks running back George Holani was named by ESPN as the player that has turned heads the most on the team with his play this offseason.
DC Wrap: Senate OKs war powers resolution; Iran contradicts U.S. on inspections
A look at the day's biggest stories in national politics
DC Wrap: Senate OKs war powers resolution; Iran contradicts U.S. on inspections
A look at the day's biggest stories in national politics
Landmark housing bill advances in Congress with bipartisan support
Measures to provide federal funding for housing production in big cities could be particularly significant to California.
Meet Caramelo, the Mexico superfan attending his 11th World Cup
Long after Mexico’s World Cup win against South Korea, fans young and old lined up outside the stadium to take photos with Héctor Chávez and his big black sombrero. Also known as Caramelo, candy in English, Chávez is arguably as well-known in Mexico as the members of the national team. Now at his 11the World Cup, Chávez is flanked by his 21-year-old son, also called Héctor Chávez, and known as Caramelo Jr. Both wear oversized sombreros with their nicknames written in all caps, making them hard to miss at stadiums.
Tickets for top entertainment events at Scotts Bluff Co. Fair go on sale Wednesday
Tickets for the ‘big three’ of the nightly entertainment at the Scotts Bluff County go on sale Wednesday morning. Starting at 9 a.m., you can get your advance tickets for the Truck and Tractor Pull…
The Steam Machine's Companion Cube case is big, expensive, and based on a 19-year-old joke, so I hate how well-made it is
The Steam Machine provides a chance to get reacquainted with the Companion Cube, courtesy of Dbrand's pricey (though admittedly finely designed) case.
Google Home gets another big update with app improvements, voice & camera upgrades
The updates keep on coming, with Google Home now rolling out yet another big update that improves on not only...
Prime Day has served up several great deals on 4K TVs
With the quality of TVs from each year getting so close, it’s a better idea to save big on last year’s models.
Business neighbors bond over common culture, community involvement
"I don't like the idea of being a business on an island." As these businesses prove, working together can make a big impact.
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Exclusive | Walmart, in Biggest Deal in Two Years, Buys Advertising Tech Firm
The retail giant is purchasing Vibe.co, a company that enables advertising through connected TVs.
Aspen Ideas: Health features four days of ‘big ideas’
Aspen Ideas: Health opened June 22 with remarks from experts, including two-minute big-idea summaries from seven health industry professionals. Since artificial intelligence is such an all-encompassing and rapidly expanding force, at least half of the big ideas revolved around AI.
Josh McBride
Amazon Prime Day is underway, and entertainment and lifestyle expert Josh McBride shared some standout deals to help shoppers save big.
'Hacks' star admits she stormed out of Emmys after losing to costar: 'Biggest sore loser'
'Hacks' star Robby Hoffman admitted she stormed out of the Emmys after losing to costar Julianne Nicholson: 'I was the biggest sore loser,' Hoffman told 'Drag Race' icon Trixie Mattel on her podcast.
11 of the Best Discounts on Desktop PCs for Amazon Prime Day From Dell, HP, Lenovo, and More
Big sale, big computers. Grab a new desktop tower, all-in-one, gaming battlestation or compact PC at a deep discount during the four-day sale.
Meet the doctor building tiny tools for big science breakthroughs
UCLA's Steven Jonas uses nanotechnology in his lab to explore cancer and other disease-fighting tools.
More psychiatric beds alone won’t fix San Antonio’s mental health challenges, experts say
San Antonio’s mental health challenges are bigger than needing more inpatient psychiatric capacity, according to experts.
Senate passes bipartisan housing bill
This is the “biggest housing bill in more than 30 years,” said Sen. Elizabeth Warren (D-Mass.)
Two women are at the center of New York’s next big political test
Mayor Zohran Mamdani has backed democratic socialist candidates Darializa Avila Chevalier and Assembly Member Claire Valdez.
MSI Claw 8 EX AI+ review: Big money for big performance
Intel and MSI have teamed up to create what might be the most powerful handheld gaming PC on the market.
One Pitt student team will get the opportunity to send their experiment to the ISS
The University is looking for undergraduates and faculty advisors with big cosmic questions — that fit in tiny packages — as part of the national Student Spaceflight Experiments Program.
Want to go big for Prime Day? 100-inch Hisense TVs are $2,000 off
Hisense Prime Day deals are live with up to $2,000 off MiniLED TVs. Shop 55- to 100-inch U7SG and U6SF Pro models on Amazon while prices last.
The best Prime Day Lego deals include 'Star Wars' ships, Disney villain cars, and more — top finds start at $28
Lego fans can save big during Amazon Prime Day, with deals on “Harry Potter,” “Star Wars,” Lego Technic, and Ninjago sets, plus builds inspired by Marvel, Disney, “Jurassic World,” Minecraft, Formula 1 racing, and more. We've rounded up Prime Day’s 17 best Lego deals, including several at their lowest prices ever
Biggest Eagles questions by position in 2026: Defense
Looking at the biggest questions for the Eagles by position on defense in 2026.
Free virtual event to connect thousands of teachers with University of Hawai‘i science research
Science educators around the world will get a front-row seat to groundbreaking research and innovation from the university and the company PocketLab during a free virtual unconference in July.
IC360 and BIG EAST Conference Expand Integrity and Compliance Partnership
NEW YORK – The BIG EAST Conference and Integrity Compliance 360 (IC360), the global technology and advisory platform for integrity and regulatory solutions in sports, sports betting, iGaming, and prediction markets, are proud to build on their comprehensive partnership.